This inventor holds 3 USPTO granted patents. Top assignees: Elan Pharma International Limited, Alkermes Pharma Ireland Limited. Active years: 2007-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2012
Title: John L Schaefer: Innovator in Pharmaceutical Evaluation Methods
Introduction
John L Schaefer is a notable inventor based in Gilbertsville, PA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the evaluation of dosage forms. With a total of 3 patents, Schaefer's work focuses on improving the effectiveness of active agent compositions.
Latest Patents
Schaefer's latest patents include innovative in vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositions. These methods are designed to assess the redispersibility of dosage forms containing poorly water-soluble active agents. The techniques utilize media that accurately represent in vivo human physiological conditions, thereby enhancing the reliability of the evaluations.
Career Highlights
Throughout his career, John L Schaefer has worked with prominent companies in the pharmaceutical industry, including Elan Pharma International Limited and Alkermes Pharma Ireland Limited. His experience in these organizations has allowed him to develop and refine his innovative methods, contributing to advancements in drug formulation and delivery.
Collaborations
Schaefer has collaborated with esteemed colleagues such as Eugene Rex Cooper and John A Bullock. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical research.
Conclusion
John L Schaefer's contributions to pharmaceutical evaluation methods have made a significant impact on the industry. His innovative approaches continue to influence the development of effective drug formulations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile